 - Prior anti-cancer treatment with chemotherapy, immunotherapy or radiotherapy within 3 weeks 6 weeks for nitrosoureas or mitomycin-C, hormonal therapy or lapatinib within 7 days, prior trastuzumab within 21 days 7 days if weekly trastuzumab or any other targeted therapy within the last 21 days prior to starting study treatment 